Literature DB >> 21427183

Review of clinical experience with ion beam radiotherapy.

A D Jensen1, M W Münter, J Debus.   

Abstract

The article describes both the early development of oncology as a core discipline at the University of Heidelberg Hospital and the first steps towards ion beam treatment, from the pilot project carried out in co-operation with the Gesellschaft für Schwerionenforschung Darmstadt to the initial start-up of clinical service at the Heidelberg Heavy Ion Centre (HIT). We present an overview, based on data published in the literature, of the available clinical evidence relating the use of ion beam therapy to treat major indications in active particle centres. A rationale for the use of particle therapy in each of these indications is given. In view of the limited availability of data, we discuss the necessity to conduct clinical trials. We also look forward towards the next activities to be undertaken at the HIT.

Entities:  

Mesh:

Year:  2011        PMID: 21427183      PMCID: PMC3473885          DOI: 10.1259/bjr/71511359

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  80 in total

1.  Proton beam radiotherapy of iris melanoma.

Authors:  Bertil Damato; Andrzej Kacperek; Mona Chopra; Martin A Sheen; Ian R Campbell; R Douglas Errington
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

2.  Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques.

Authors:  Daniela Schulz-Ertner; Anna Nikoghosyan; Bernd Didinger; Marc Münter; Oliver Jäkel; Christian P Karger; Juergen Debus
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

3.  Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy.

Authors:  Allen M Chen; Phillip J Granchi; Joaquin Garcia; M Kara Bucci; Karen K Fu; David W Eisele
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-22       Impact factor: 7.038

4.  Hypofractionated radiotherapy with carbon ion beams for prostate cancer.

Authors:  Hiroshi Tsuji; Takeshi Yanagi; Hitoshi Ishikawa; Tadashi Kamada; Jun-Etsu Mizoe; Tatsuaki Kanai; Shinroku Morita; Hirohiko Tsujii
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-28       Impact factor: 7.038

5.  Carbon ion radiotherapy of skull base chondrosarcomas.

Authors:  Daniela Schulz-Ertner; Anna Nikoghosyan; Holger Hof; Bernd Didinger; Stephanie E Combs; Oliver Jäkel; Christian P Karger; Lutz Edler; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-10-23       Impact factor: 7.038

6.  Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.

Authors:  Damien C Weber; Hans Peter Rutz; Eros S Pedroni; Alessandra Bolsi; Beate Timmermann; Jorn Verwey; Antony J Lomax; Gudrun Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

7.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

Authors:  Anthony L Zietman; Michelle L DeSilvio; Jerry D Slater; Carl J Rossi; Daniel W Miller; Judith A Adams; William U Shipley
Journal:  JAMA       Date:  2005-09-14       Impact factor: 56.272

8.  Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen.

Authors:  Tadaaki Miyamoto; Masayuki Baba; Naoyoshi Yamamoto; Masashi Koto; Toshiyuki Sugawara; Tomoyasu Yashiro; Kennoshuke Kadono; Hidefumi Ezawa; Hirohiko Tsujii; Jun-Etsu Mizoe; Kyosan Yoshikawa; Susumu Kandatsu; Takehiko Fujisawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-01       Impact factor: 7.038

9.  Extracranial chordoma: Outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation.

Authors:  Hans Peter Rutz; Damien C Weber; Shinji Sugahara; Beate Timmermann; Antony J Lomax; Alessandra Bolsi; Eros Pedroni; Adolf Coray; Martin Jermann; Gudrun Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-02       Impact factor: 7.038

10.  Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II dose-escalation study.

Authors:  Hiroshi Tsuji; Hitoshi Ishikawa; Takeshi Yanagi; Naoki Hirasawa; Tadashi Kamada; Jun-Etsu Mizoe; Tatsuaki Kanai; Hirohiko Tsujii; Yoshitaka Ohnishi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-08       Impact factor: 7.038

View more
  8 in total

1.  Particle therapy.

Authors:  S Green
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  The microdosimetric extension in TOPAS: development and comparison with published data.

Authors:  Hongyu Zhu; Yizheng Chen; Wonmo Sung; Aimee L McNamara; Linh T Tran; Lucas N Burigo; Anatoly B Rosenfeld; Junli Li; Bruce Faddegon; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2019-07-11       Impact factor: 3.609

Review 3.  The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models.

Authors:  Takashi Shimokawa; Liqiu Ma; Ken Ando; Katsutoshi Sato; Takashi Imai
Journal:  Int J Part Ther       Date:  2016-08-29

4.  Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.

Authors:  Claudia Blattmann; Susanne Oertel; Markus Thiemann; Anne Dittmar; Eva Roth; Andreas E Kulozik; Volker Ehemann; Wilko Weichert; Peter E Huber; Albrecht Stenzinger; Jürgen Debus
Journal:  Radiat Oncol       Date:  2015-07-16       Impact factor: 3.481

5.  Proteomic Analysis Implicates Dominant Alterations of RNA Metabolism and the Proteasome Pathway in the Cellular Response to Carbon-Ion Irradiation.

Authors:  Yu Wang; Hua Guan; Da-Fei Xie; Yi Xie; Xiao-Dan Liu; Qi Wang; Li Sui; Man Song; Hong Zhang; Jianhua Zhou; Ping-Kun Zhou
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

6.  Heavy-Ion Carbon Radiation Regulates Long Non-Coding RNAs in Cervical Cancer HeLa Cells.

Authors:  Zhi Yang; Qingying Gu; Ying Wang; Bo Liu; Guangming Zhou; Chunlin Shao; Jing Ruan; Renbing Jia; Shengfang Ge
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

7.  Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution.

Authors:  Benjamin A Högerle; Felix Lasitschka; Thomas Muley; Nina Bougatf; Klaus Herfarth; Sebastian Adeberg; Martin Eichhorn; Jürgen Debus; Hauke Winter; Stefan Rieken; Matthias Uhl
Journal:  Radiat Oncol       Date:  2019-07-04       Impact factor: 4.309

8.  In vitro engineering of human 3D chondrosarcoma: a preclinical model relevant for investigations of radiation quality impact.

Authors:  Dounia Houria Hamdi; Sofia Barbieri; François Chevalier; Jean-Emmanuel Groetz; Florence Legendre; Magali Demoor; Philippe Galera; Jean-Louis Lefaix; Yannick Saintigny
Journal:  BMC Cancer       Date:  2015-08-08       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.